Protocol · graded by use, six uses
Gratitude practice: gratitude journals, lists and letters
Graded on: self-reported well-being, positive affect and depressive symptoms on validated questionnaires (for example the PANAS, the Satisfaction with Life Scale, the CES-D and the PHQ).
At a glance
This page is about gratitude practice, such as writing down things you are thankful for or writing a thank-you letter. Many trials found people felt a little better and had fewer signs of depression afterward. These things are measured by asking people. Other exercises worked about as well. A few small trials looked at sleep, blood pressure and inflammation, with mixed results. No trial has tested whether gratitude helps people live longer.
- What was measured
- How good people said they felt, and signs of depression, on question scales, before and after a few weeks of gratitude writing.
- How big
- In one trial of hospital staff, depression scores were 1.50 points lower with a gratitude diary than with no diary, an effect size How large a difference the treatment made, as distinct from whether the difference could be detected at all. of 0.49, a moderate change.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 25222798.
- Who it applies to
- Mostly healthy adults, students and health care staff, plus some patients in therapy or in the hospital. Trials of the body, such as blood pressure, were small.
- Safety
- No serious harm is on file. In one lab trial, people who had just done a gratitude exercise found a cold-water stress test more unpleasant than others did.
- Compared with
- No writing, a waiting list, or writing about everyday events, hassles or food, depending on the trial.
- Certainty
- Grade B, resting on: Meta-analyses A study that pools the numbers from several trials into one combined estimate. of randomized trials and randomized trials (well-being, depressive symptoms, sleep, blood pressure, inflammation markers); a cohort study An observational study that follows a group of people over time and compares what happens to them. of gratitude and mortality is listed as excluded evidence and carries no letter.
- What would change this grade
- Could rise to A with: Randomized trial of a defined gratitude practice against an active writing control, run by a group independent of earlier trials. Who: Adults with high blood pressure or adults aged 60 and over. Measured: Blood pressure measured over 24 hours, with sleep measured by device and depressive symptoms on a clinician-rated scale. Length: At least 6 months.
- Cost
- No price recorded yet.
- Sources
- 25 studies cited on this record, listed under Sources.
- For clinicians
- A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
The B is shared by two of the six uses graded on this record, each on its own evidence. The other four carry their own letters.
This record carries a separate letter for each thing it has been measured on. The headline grade is the best of them, and it does not transfer to the others.
Choi et al. (Proceedings of the National Academy of Sciences, 2025; PMID 40627390) pooled 163 samples and 24,804 participants: well-being rose by g = 0.19, a small effect, robust to publication bias and larger in randomized trials. Davis et al. (Journal of Counseling Psychology, 2016; PMID 26575348) found gratitude beat measurement-only and alternative-activity controls but performed no better than psychologically active comparisons (d = -0.03). Independent randomized trials in the United States, Brazil and Ireland found gains in positive affect (PMIDs 12585811, 30949102, 28263399); a Spanish replication The same finding reproduced by a separate research group. A result seen once can be chance or bias; a replicated one is harder to explain away. held only partly (PMID 20977036), and a 2-week app trial in parents found no effect (PMID 40489175). A small, replicated effect on a self-reported outcome: B.
Cheng et al. (Journal of Consulting and Clinical Psychology, 2015; PMID 25222798): 102 hospital practitioners, depressive symptoms 1.50 points lower than with no diary at 3 months (d = -0.49). Kalon et al. (2025; PMID 40516624): 352 adults, depression d = 0.41 against a wait list. Titov et al. (2026; PMID 42285012): 305 health professionals, lower depression and anxiety scores against a wait list. Ducasse et al. (2019; PMID 30657226): 201 hospitalized adults, depression improved more than with a food diary, suicidal ideation did not differ. Wong et al. (2018; PMID 27139595): 293 psychotherapy clients, better mental health at 12 weeks. Diniz et al. (2023; PMID 37585888) pooled 64 trials with fewer depression and anxiety symptoms. Against this, one small trial in breast cancer found no change in depression (PMID 40722069), and a student trial found benefit only with at least moderate symptoms (PMID 39810453). Replicated across independent groups on a self-reported scale: B.
Boggiss et al. (Journal of Psychosomatic Research, 2020; PMID 32590219) reviewed 19 randomized trials with physical health outcomes: subjective sleep quality improved in 5 of the 8 that measured it, and most trials showed some risk of bias. Jackowska et al. (2016; PMID 25736389) found better sleep quality after 2 weeks in 119 young women. Mixed results on a self-rated outcome, and no trial measured sleep by device: C.
Jackowska et al. (Journal of Health Psychology, 2016; PMID 25736389): 119 young women, diastolic blood pressure fell with gratitude writing, and cortisol did not change. The systematic review A review that searches for every study on a question using a method set in advance, then assesses them together. found this the only gratitude trial with a blood pressure outcome (PMID 32590219). A multi-part spirituality program that included gratitude lowered office systolic pressure in hypertension (listed below as a trial not counted), but gratitude was one of four parts, so it does not count as a replication. A single trial not independently repeated: C under Rule 06.
Redwine et al. (Psychosomatic Medicine, 2016; PMID 27187845): a pilot in 70 patients with Stage B heart failure, the inflammatory biomarker A measurable sign in the body, such as a blood test value, used to track a condition or the effect of a treatment. index fell against treatment as usual, resting heart rate variability did not differ, and the authors call for larger trials with active controls. Hazlett et al. (Brain, Behavior, and Immunity, 2021; PMID 33932527): 61 healthy women, no significant group differences in brain responses and no group effect on inflammatory markers reported. An inflammation index is not an established stand-in for a clinical outcome, so this use cannot rise above C, and the two trials disagree.
No randomized trial has tested whether gratitude practice lowers death or heart disease. The association comes from a cohort: in 49,275 older women in the Nurses' Health Study, the most grateful third had lower all-cause and cardiovascular mortality (Chen et al., JAMA Psychiatry, 2024; PMID 38959002). It is listed as excluded evidence and carries no letter. D here means the trial has not been run, not that one failed.
Raising self-reported well-being and positive mood with gratitude journals, lists or letters, a small effect (B). Lowering self-reported depressive symptoms, in health care staff, psychotherapy clients, hospitalized patients and the general population (B). Self-rated sleep quality: mixed trials (C). Blood pressure: one trial (C). Inflammation markers: one positive pilot and one trial without a group difference (C). Death and heart disease: no randomized trial (D).
Why this letter
Why this gradeThe reasoning, and what the grade does not cover.
Grade B on self-reported well-being: a preregistered meta-analysis of 163 samples and 24,804 participants finds a small, consistent gain (g = 0.19; PMID 40627390), replicated across independent research groups in many countries (PMIDs 12585811, 30949102, 28263399), with one null trial in parents (PMID 40489175). Self-reported endpoints The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. cap a record at B. Grade B on self-reported depressive symptoms: independent randomized trials in Hong Kong, Germany, Australia, France and the United States lowered depressive symptoms against no diary, wait lists or a food diary (PMIDs 25222798, 40516624, 42285012, 30657226, 27139595), supported by a meta-analysis of 64 trials (PMID 37585888); self-reported, so B. Grade C on self-rated sleep quality: improved in 5 of 8 trials (PMID 32590219), mixed. Grade C on blood pressure: one trial (PMID 25736389), not independently repeated (Rule 06). Grade C on inflammation markers: one positive pilot (PMID 27187845) and one trial without a group difference (PMID 33932527); an inflammation index is not an established stand-in for a clinical outcome, so it cannot rise above C. Grade D on death and heart disease: no randomized trial.
WHAT THIS GRADE DOES NOT COVERanxiety, where results are mixed (PMIDs 26575348, 42285012); whether gratitude beats other active exercises, which a meta-analysis found it does not (PMID 26575348); the cohort link between gratitude and lower mortality (PMID 38959002), which carries no letter under Rule 05.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Trials report an average. This box says whether any trial on this record looked at who the result applies to, and what it found.
For this record's Grade B · Subgroup tested, effect differedKalon et al. (Journal of Affective Disorders, 2025; PMID 40516624) found a larger effect in participants who screened positive for depression (d = 0.55) than in the rest (d = 0.35). Fuller et al. (JMIR mHealth and uHealth, 2025; PMID 39810453) found lower depression, anxiety and stress only in students with at least moderate symptoms at baseline. A subgroup result shows who the effect appeared in within these trials. It does not change the letter.
Evidence notes: meta-analysis, randomized trial
Endpoint graded: Self-reported well-being, positive affect and depressive symptoms on validated questionnaires (for example the PANAS, the Satisfaction with Life Scale, the CES-D and the PHQ) (self_report)
Last reviewed: November 2026
The trial that would change this grade.
Positive trials of this shape from independent research groups would move this entry to A.
Why the current trials fall short
The well-being and depression results rest on questionnaires people fill in themselves, and the blood pressure result rests on one trial in young women (Jackowska et al., 2016; PMID 25736389). A blinded clinician-rated or device-measured outcome that replicates could raise the depression use; blood pressure would rise to B with a replicating trial.
ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Gratitude among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.
Search recruiting studies of Gratitude on ClinicalTrials.gov
Dose, form and timing
Measured outcome: well-being, mood and depressive symptoms scored on validated questionnaires before and after a few weeks of gratitude writing. Some trials also measured self-rated sleep quality (PMID 25736389), blood pressure (PMID 25736389), and blood inflammation markers (PMIDs 27187845, 33932527).
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Safety
Cautions documented in human studies. Each caution on this record, sorted by what it rests on.
- Stress reaction: in one laboratory trial, a brief gratitude practice was followed by a stronger negative reaction to a cold-water stress test (PMID 30540772)
None recorded.
None recorded.
None recorded.
Does not apply: human harm data are listed above.
Grade history
How this letter has changedLatest: No. 480 · November 2026 · First graded.
Gratitude practice now has its own record, graded use by use after a PubMed search in November 2026. Randomized trials find a small, replicated gain in self-reported well-being (Choi et al., 2025; PMID 40627390) and lower self-reported depressive symptoms (Cheng et al., 2015; PMID 25222798): B, the ceiling for self-reported outcomes. Self-rated sleep quality is mixed, blood pressure rests on one trial (Jackowska et al., 2016; PMID 25736389), and inflammation markers rest on one pilot that a second trial did not confirm: C. No randomized trial has tested death or heart disease: D. A cohort of older nurses linking gratitude with lower mortality (Chen et al., 2024; PMID 38959002) describes people, not the effect of a practice, and carries no letter. Applied the written grade definitions under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 40627390 PMID 25222798 PMID 25736389 PMID 38959002
Every change to a letter on this site is dated and published. The full evidence log →
Sources
- Citations
- Every paper cited on this page is matched to its PubMed record on every build.
- Retractions
- None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
- Read against the papers
- November 2026. By the EBL editor, Arnold Sandlow, DC.
- Outside review
- Not yet done. No reviewer outside EBL has checked this record.
What each of these checks can and cannot show: evidence integrity.
The evidence, in full25 papers, each linked to its PubMed record.
Well-being: Choi et al. (Proceedings of the National Academy of Sciences, 2025; PMID 40627390), preregistered meta-analysis of 145 papers, 163 samples and 24,804 participants in 28 countries, overall well-being Hedges' g 0.19 (95% CI 0.15 to 0.22), robust to publication bias, larger in randomized controlled trials People are assigned to the treatment or a comparison by chance, so the groups differ only in what they received. It is the design that can show cause and effect.; Davis et al. (Journal of Counseling Psychology, 2016; PMID 26575348), gratitude interventions outperformed measurement-only controls on psychological well-being (d = 0.31) and alternative activities (d = 0.17), performed no better than psychologically active comparisons (d = -0.03), and did not reduce anxiety (d = 0.11, 5 studies); Diniz et al. (Einstein, 2023; PMID 37585888), 64 randomized trials, better mental health and fewer symptoms of anxiety and depression. Emmons and McCullough (Journal of Personality and Social Psychology, 2003; PMID 12585811), three randomized studies of gratitude listing, positive affect the most robust effect. Martinez-Marti et al. (Spanish Journal of Psychology, 2010; PMID 20977036), a replication that held only partly once baseline and follow-up measures were included. Cunha et al. (Frontiers in Psychology, 2019; PMID 30949102), 1,337 adults randomized to 14 days of gratitude lists or two comparison lists, positive affect rose more than in the controls, with 410 analyzed after dropout. O'Connell et al. (Journal of Clinical Psychology, 2017; PMID 28263399), 192 adults, interpersonal gratitude journals improved affect balance against an active control. Null: Ratcliff et al. (Journal of Family Psychology, 2025; PMID 40489175), 125 parents of young children, a 2-week app-based gratitude program did not differ from an attention control on any outcome. Depressive symptoms: Cheng et al. (Journal of Consulting and Clinical Psychology, 2015; PMID 25222798), 102 hospital practitioners, a work gratitude diary lowered depressive symptoms (-1.50 points, d = -0.49) and perceived stress (d = -0.95) against no diary at 3 months; Heckendorf et al. (Behaviour Research and Therapy, 2019; PMID 31202003), 260 adults with high repetitive negative thinking, an internet gratitude program against a wait list, d = 0.61 on repetitive negative thinking with small to moderate effects on secondary outcomes; Kalon et al. (Journal of Affective Disorders, 2025; PMID 40516624), 352 adults, a gratitude app lowered depression (d = 0.41) against a wait list; Titov et al. (Behaviour Research and Therapy, 2026; PMID 42285012), 305 Australian health professionals, text-message gratitude prompts lowered depression and anxiety scores against a wait list, no better than prompts for other everyday actions; Ducasse et al. (Depression and Anxiety, 2019; PMID 30657226), 201 adults hospitalized for suicidal ideation or attempt, a 7-day gratitude diary improved depression, anxiety and optimism more than a food diary, with no difference in suicidal ideation; Wong et al. (Psychotherapy Research, 2018; PMID 27139595), 293 psychotherapy clients, gratitude letters added to therapy improved mental health at 4 and 12 weeks against therapy alone or expressive writing; Fuller et al. (JMIR mHealth and uHealth, 2025; PMID 39810453), 120 students, a gratitude app lowered depression, anxiety and stress only in those with at least moderate symptoms; Shariatmadari et al. (BMC Cancer, 2025; PMID 40722069), 45 women with breast cancer, neither gratitude nor behavioral activation lowered depression scores. Physical health: Boggiss et al. (Journal of Psychosomatic Research, 2020; PMID 32590219), systematic review of 19 randomized trials, subjective sleep quality improved in 5 of 8, blood pressure, glycemic control and asthma control each in a single study, inflammation markers in 1 of 2 and self-reported physical symptoms in 2 of 8, most with some risk of bias; Jackowska et al. (Journal of Health Psychology, 2016; PMID 25736389), 119 young women, 2 weeks of gratitude writing against an active control and no treatment, better sleep quality and lower diastolic blood pressure, no change in cortisol; Redwine et al. (Psychosomatic Medicine, 2016; PMID 27187845), 70 patients with Stage B heart failure, 8 weeks of gratitude journaling against treatment as usual, lower inflammatory biomarker index, no difference in resting heart rate variability; Hazlett et al. (Brain, Behavior, and Immunity, 2021; PMID 33932527), 61 healthy women aged 35 to 50, 6 weeks of gratitude writing against control writing, no significant group differences in brain responses and no group effect on inflammatory markers reported. Safety: Hirshberg et al. (PLoS One, 2018; PMID 30540772), 156 undergraduates randomized to brief breath awareness, loving-kindness, gratitude or a control practice; gratitude raised positive affect but was followed by a stronger negative reaction to a cold-water stress test than the other practices. Not graded here: Schache et al. (Diabetic Medicine, 2020; PMID 31315150), 80 adolescents with type 1 diabetes, no group differences in psychological measures, HbA1c A blood test that reflects average blood sugar over the previous two to three months. stable with gratitude and slightly higher in controls, significant only after adjusting for baseline. Population evidence, not graded: Chen et al. (JAMA Psychiatry, 2024; PMID 38959002), 49,275 older women in the Nurses' Health Study.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
gratitude[ti] AND (intervention*[tiab] OR journal*[tiab] OR letter*[tiab] OR list*[tiab] OR exercise*[tiab]) AND (randomized controlled trial[pt] OR meta-analysis[pt])PubMed watch: does a new study change the grade? (nothing new)
No new paper matching the search behind this grade has been added to PubMed since November 2026.
Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.
For each trial behind a letter on this page, the funding its PubMed record lists. "No funder" means PubMed lists none, not that the trial had no funding.
- Emmons et al., 2003, J Pers Soc Psychol (PMID 12585811): PubMed lists no funder for this trial.
- Martínez-Martí et al., 2010, Span J Psychol (PMID 20977036): PubMed lists no funder for this trial.
- O'Connell et al., 2017, J Clin Psychol (PMID 28263399): PubMed lists no funder for this trial.
- Ratcliff et al., 2025, J Fam Psychol (PMID 40489175): PubMed lists no funder for this trial.
- Cheng et al., 2015, J Consult Clin Psychol (PMID 25222798): PubMed lists no funder for this trial.
- Heckendorf et al., 2019, Behav Res Ther (PMID 31202003): PubMed lists no funder for this trial.
- Kalon et al., 2025, J Affect Disord (PMID 40516624): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.
- Titov et al., 2026, Behav Res Ther (PMID 42285012): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.
- Ducasse et al., 2019, Depress Anxiety (PMID 30657226): PubMed lists no funder for this trial.
- Wong et al., 2018, Psychother Res (PMID 27139595): PubMed lists no funder for this trial.
- Fuller et al., 2025, JMIR Mhealth Uhealth (PMID 39810453): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.
- Shariatmadari et al., 2025, BMC Cancer (PMID 40722069): PubMed lists funding from Qom University of Medical Science. The PubMed record carries a competing-interest statement.
- Jackowska et al., 2016, J Health Psychol (PMID 25736389): PubMed lists funding from British Heart Foundation; Biotechnology and Biological Sciences Research Council.
- Redwine et al., 2016, Psychosom Med (PMID 27187845): PubMed lists funding from US National Institutes of Health (National Heart, Lung, and Blood Institute).
- Hazlett et al., 2021, Brain Behav Immun (PMID 33932527): PubMed lists no funder for this trial.
- Schache et al., 2020, Diabet Med (PMID 31315150): PubMed lists no funder for this trial.
- Teixeira et al., 2025, Glob Heart (PMID 39867664): PubMed lists no funder for this trial. The PubMed record carries a competing-interest statement.
- Cousin et al., 2024, BMC Psychiatry (PMID 39696111): PubMed lists funding from US National Institutes of Health (National Institute on Aging); University of Florida Claude D. Pepper Older Americans Independence Center. The PubMed record carries a competing-interest statement.
- Hirshberg et al., 2018, PLoS One (PMID 30540772): PubMed lists funding from US National Institutes of Health (National Center for Complementary and Integrative Health). The PubMed record carries a competing-interest statement.
Disclosure
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →